Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Navigating the complex landscape of drug approval presents significant regulatory challenges, requiring a delicate balance between fostering pharmaceutical innovation and ensuring patient safety. The ...

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) has begun piloting a fast-track registration pathway for products authorized in the European Union or United States.

DENVER — A "huge" number of life-years is being unnecessarily lost because of delays in cancer drug approvals, according to research presented here at the 16th World Conference on Lung Cancer. Every ...

A new piece of legislation introduced today by a bipartisan congressional duo calls for the improvement of a current regulatory stumbling block that some companies have likened to a "black hole." ...

Biosimilar Regulatory Process The goal of the BPCIA is similar in concept to the Hatch-Waxman Act of 1984. Hatch-Waxman created the existing approval framework for "small molecule" generics where an ...

It is crucial to understand the drug development process and the many milestones and tasks that are essential to a comprehensive development plan to guarantee scientific and commercial success. While ...

WASHINGTON, DC - MAY 12: (L-R) National Institutes of Health (NIH) Director Jay Bhattacharya, Administrator for the Centers for Medicare & Medicaid Services (CMS) Mehmet Oz, U.S. President Donald ...

Industry concerned over immediate licence cancellation on NSQ drug reports without due process: Shardul Nautiyal, Mumbai Wednesday, May 27, 2026, 08:00 Hrs [IST] The pharmaceutica ...